key: cord-0983914-yo6u4qkq authors: Mullan, Clancy; Powierza, Camilla; Miller, P. Elliott; Geirsson, Arnar; Vallabhajosyula, Prashanth; Assi, Roland title: Spontaneous coronavirus disease 2019 (COVID-19)-associated luminal aortic thrombus date: 2020-06-09 journal: J Thorac Cardiovasc Surg DOI: 10.1016/j.jtcvs.2020.05.024 sha: 077148635588618470fe8d8022c1495542705315 doc_id: 983914 cord_uid: yo6u4qkq nan To the Editor: Coronavirus disease 2019 (COVID-19) has been associated with profound coagulopathies via direct and indirect mechanisms. 1 Aortic thrombus is typically identified in atherosclerotic or aneurysmal aortas and can be discovered as a rare embolic source. 2 We report 2 cases of aortic intraluminal thrombi without history of aortic disease, vasculitis, or coagulopathy. Patient 1 was a 62-year-old male patient with hyperlipidemia who presented with diarrhea and hypoxia and was diagnosed with COVID-19 on April 28, 2020. He was supported for 72 hours then progressed to hypoxic respiratory failure requiring mechanical ventilation. His presenting laboratory work was notable for D-dimer of 1.19 mg/L (normal <0.57 mg/L) and fibrinogenemia to 728 mg/dL (normal <464 mg/dL). He was started on 160 mg of subcutaneous enoxaparin daily. His D-dimer increased to 14.87 mg/L at the time of decompensation. An emergent computed tomography (CT) scan with pulmonaryƀarterial-phase contrast was obtained. A large ascending intraluminal thrombus, as well as a distinct proximal descending thoracic aortic intraluminal thrombus, was found with normal aortic size and wall thickness and without calcifications (Figure 1, A) . No echocardiographic evidence of ventricular thrombus or endocarditis was found. CT of his brain identified a large right parietal stroke. A multidisciplinary team agreed to low-dose heparin infusion, without an antiplatelet agent, and repeat CT angiography in approximately 2 weeks to ensure thrombus dissolution. Patient 2 was a 57-year-old male patient with diabetes mellitus, hypertension, hyperlipidemia, and previous transient ischemic attack who developed fevers and myalgias and was diagnosed with COVID-19 via reversetranscription polymerase chain reaction Q3 on April 16, 2020. Presentation studies were notable for a normal D-dimer of 0.46 mg/L. His home medications included daily aspirin, which was continued throughout his hospitalization, along with enoxaparin prophylaxis. Shortly thereafter, he was transferred to the intensive care unit for hypoxic respiratory failure requiring noninvasive positive pressure ventilation. On hospital day 9, he developed acute abdominal pain and an elevated lactate of 3.1 mmol/L. His D-dimer peaked at 29.97 mg/L the same day. An emergent CT of his abdomen and pelvis identified bilateral renal infarcts and distal thoracic aortic thrombus, in an otherwiseunremarkable aorta (Figure 1, B) . He was also started on a heparin infusion, which resulted in a return of his distal pulses. The biologic underpinnings of COVID-19-related coagulopathy are complex, 1 and acute aortic thrombus related to COVID-19 infection has been described only once to The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. https://doi.org/10.1016/j.jtcvs.2020.05.024 Letter to the Editor e2 The Journal of Thoracic and Cardiovascular Surgery c -2020 COR 5.6.0 DTD YMTC16247_proof 8 June 2020 6:28 pm ce JM 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up Aortic mural thrombus in the normal or minimally atherosclerotic aorta Concomitant acute aortic thrombosis and pulmonary embolism complicating COVID-19 pneumonia